Elite Pharmaceuticals, Inc. is a leading specialty pharmaceutical company focused on developing and manufacturing oral, controlled-release drug products. Leveraging proprietary technologies, Elite creates high-barrier generic pharmaceuticals to address complex therapeutic needs. Elite maintains a strong foothold in the generic pharmaceutical industry with a portfolio that includes multiple generic products, some licensed to Prasco, LLC and TAGI Pharma.
Operating from a cGMP and DEA-registered facility in Northvale, NJ, Elite Pharmaceuticals is committed to upholding the highest quality standards. The company meets rigorous FDA regulations, ensuring excellence in every stage of product development and manufacturing. Known for its innovation and regulatory expertise, Elite Pharmaceuticals continues to serve both domestic and international markets with its broad range of oral solids and semi-solid dosage forms.
Elite Pharmaceuticals faced significant hurdles with their existing methods of stability data management, resulting in operational inefficiencies. Key challenges included:
To learn how Elite Pharmaceuticals overcame these challenges with the implementation of a robust Stability Management System, fill out the form below to download the full case study!
© 2026 AmpleLogic. All rights reserved.